Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Other Working Capital Changes (2016 - 2025)

Lipocine (LPCN) has disclosed Other Working Capital Changes for 13 consecutive years, with $321168.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Working Capital Changes rose 10.07% year-over-year to $321168.0, compared with a TTM value of $94973.0 through Sep 2025, up 157.05%, and an annual FY2024 reading of $1495.0, up 100.45% over the prior year.
  • Other Working Capital Changes was $321168.0 for Q3 2025 at Lipocine, up from -$66166.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.3 million in Q3 2021 and bottomed at -$774379.0 in Q2 2022.
  • Average Other Working Capital Changes over 5 years is -$7297.4, with a median of -$96803.0 recorded in 2023.
  • The sharpest move saw Other Working Capital Changes plummeted 891.28% in 2022, then skyrocketed 401.41% in 2024.
  • Year by year, Other Working Capital Changes stood at -$29176.0 in 2021, then tumbled by 891.28% to -$289217.0 in 2022, then surged by 106.27% to $18137.0 in 2023, then tumbled by 215.28% to -$20909.0 in 2024, then skyrocketed by 1636.03% to $321168.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for LPCN at $321168.0 in Q3 2025, -$66166.0 in Q2 2025, and -$139120.0 in Q1 2025.